Buy-Sell Agreement (UK)

A Buy-Sell Agreement in the United Kingdom is a legally binding written instrument.

Buy-sell agreements for UK limited companies operate alongside — and must be consistent with — the company's articles of association. Under the Companies Act 2006, the articles of association govern the transfer of shares. Most companies incorporated in England and Wales use a version of the Model Articles for Private Companies Limited by Shares (set out in Schedule 1 to the Companies (Model Articles) Regulations 2008), which include pre-emption rights requiring shares to be offered to existing shareholders before being transferred to outsiders. A buy-sell agreement provides the more detailed commercial terms — including the triggering events, the valuation formula, the funding structure, and the payment schedule — that the articles do not address. The buy-sell agreement and the articles must be reviewed together by a corporate solicitor to confirm they do not conflict; any conflict must be resolved by amending the articles under section 21 of the Companies Act 2006.

For partnerships and limited liability partnerships (LLPs), buy-sell provisions are typically incorporated into the partnership agreement or LLP agreement rather than a standalone buy-sell agreement. The Partnership Act 1890 (which applies to traditional partnerships) and the Limited Liability Partnerships Act 2000 (which governs LLPs) provide default rules on dissolution and the rights of partners, but these defaults are generally unfavourable and should be overridden by an express agreement.

The tax treatment of a buy-sell transaction in the UK is complex and depends on the structure. A shareholder who sells their shares under the buy-sell mechanism will typically realise a capital gain subject to Capital Gains Tax (CGT). Business Asset Disposal Relief (BADR, formerly Entrepreneurs' Relief) under sections 169H to 169S of the Taxation of Chargeable Gains Act 1992 may reduce the CGT rate to 10% on qualifying gains, subject to the £1 million lifetime limit and the conditions being met (broadly, the seller must have held at least 5% of the shares and voting rights for at least two years). A company buyback of its own shares may be treated as a distribution subject to income tax unless the capital treatment conditions in sections 1033 to 1048 of the Corporation Tax Act 2010 are satisfied. HMRC clearance for capital treatment is advisable for significant buybacks.

A UK Buy-Sell Agreement is needed by any business with two or more co-owners — whether shareholders in a limited company, partners in a partnership, or members of an LLP — who wish to plan for business continuity in the event that one owner departs, dies, or becomes incapacitated.

Small family businesses with two or more family members as shareholders particularly need buy-sell agreements because the consequences of a shareholder's unexpected death — the deceased's shares passing under their will or the intestacy rules to a family member who may have no connection to the business — can be immediately disruptive. The buy-sell agreement pre-agrees that the remaining family owners can buy out the deceased's estate, and the cross-option life assurance arrangement provides the funding to do so.

Start-ups and growth businesses with two or more co-founders need buy-sell provisions in their shareholder agreement from the outset. Investors — including venture capital funds, private equity houses, and angel investors — routinely require drag-along rights, tag-along rights, and exit provisions as a condition of investment. A buy-sell agreement formalises the co-founders' arrangements ahead of the investor negotiation.

Medical practices, law firms, and other professional services partnerships in England and Wales need buy-sell provisions in their partnership deeds to manage succession when senior partners retire or die. The Law Society and the British Medical Association publish guidance on buy-sell provisions appropriate for professional partnerships.

A buy-sell agreement is also needed when a business takes out key person life assurance or critical illness cover on shareholder-directors. The insured event (death or critical illness) triggers the buy-sell mechanism, and the insurance proceeds fund the buyout. Without a buy-sell agreement, the timing and mechanism for using the insurance proceeds to fund the transfer is undefined.

Businesses preparing for a sale — whether to a trade buyer, a private equity sponsor, or through a management buyout (MBO) — benefit from having a buy-sell agreement in place to confirm all shareholders are committed to the exit process and that any dissenting minority shareholders are subject to drag-along obligations.

A UK Buy-Sell Agreement must address the following key provisions to be effective and tax-efficient under English law and HMRC rules.

Triggering events define the circumstances that activate the buy-sell mechanism. Standard triggering events include: death; permanent and total disability (defined by reference to the relevant insurance policy); retirement or voluntary exit; bankruptcy or insolvency of a shareholder; a shareholder being convicted of a serious criminal offence; a shareholder committing a serious breach of the shareholder agreement or service agreement; and a forced transfer (for example, where a shareholder's spouse or former spouse seeks to claim a share of the business interest in divorce proceedings). Each triggering event may have different consequences — for example, the price may differ for a voluntary exit versus a death.

Valuation mechanism is the most commercially important provision. Common approaches include: a fixed price (agreed annually and updated at each review); a formula-based valuation (for example, a multiple of EBITDA, with the multiple and the earnings figure defined); or an independent professional valuation by a chartered accountant or business valuer appointed by the ICAEW (Institute of Chartered Accountants in England and Wales) or nominated by the president of the relevant professional body. The agreement should specify how disagreements about valuation are resolved — typically by expert determination under the terms of the Arbitration Act 1996.

Funding mechanism addresses how the purchasing owners will fund the buyout. The most common structure for shareholder death is a cross-option arrangement linked to life assurance policies, which HMRC has confirmed preserves Business Property Relief for inheritance tax purposes on the deceased's shares (provided the options are separate and neither party is obliged to buy or sell until the option is exercised). Key person insurance, critical illness cover, and shareholder protection policies are the typical insurance products used.

Pre-emption rights and transfer restrictions confirm that the buy-sell provisions operate consistently with the articles of association's pre-emption provisions under the Companies Act 2006. The agreement should specify the order in which remaining shareholders may acquire the departing shareholder's interest (for example, pro rata to existing shareholdings, or in agreed priority order).

Payment terms set out how the purchase price will be paid — whether as a lump sum on completion, deferred in instalments, or through a combination. Where deferred payments are agreed, the agreement should address the interest rate on outstanding amounts (referencing the Late Payment of Commercial Debts (Interest) Act 1998 or a separately agreed rate) and the security (if any) for payment.

Non-compete and non-solicitation covenants imposed on the departing shareholder protect the remaining owners from competition. These covenants must be reasonable in scope, duration, and geographic extent to be enforceable under English law — the High Court in Beckett Investment Management Group Ltd v Hall [2007] EWCA Civ 613 confirmed that post-exit restrictions must go no further than necessary to protect the legitimate business interests of the remaining owners. The forms-legal.com Buy-Sell Agreement (UK) template covers the mandatory elements under Companies Act 2006.